CRP and cancer: In this context, inflammation emerges as a pivotal oncogenic mechanism, with biomarkers such as IL-6, TNF-α, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and fibrinogen representing clinically relevant indicators for integrative cancer risk assessment.